Biological Safety Cabinet Market worth $0.36 billion by 2031
The report "Biological Safety Cabinet Market by Type (Class I, Class II [Type A, Type B, Type C1], Class III), End User (Pharma & Biopharma Organization, Clinical Laboratories, Academic & Biomedical Research Institutes, Others), and Region - Global Forecast to 2031" is projected to be valued at USD 0.26 billion in 2026 and USD 0.36 billion by 2031, exhibiting a CAGR of 6.6%.
Browse 160 market data Tables and 40 Figures spread through 220 Pages and in-depth TOC on "Biological Safety Cabinet Market, by Type (Class I, Class II [Type A, Type B, Type C1], Class III), End User (Pharma & Biopharma Organization, Clinical Laboratories, Academic & Biomedical Research Institutes, Others), and Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/biological-safety-cabinet-market-60228904.html
The global biological safety cabinet market is primarily driven by the expansion of pharmaceutical and biopharmaceutical research, increasing laboratory testing, and growing requirements for personnel, product, and environmental protection when handling infectious agents and biological materials. Rising investments in drug discovery, biologics, vaccines, cell and gene therapies, and clinical diagnostics are supporting demand for biological safety cabinets across research and laboratory facilities. Class II cabinets are particularly important because they provide personnel, product, and environmental protection and are widely used for work involving biological agents across multiple biosafety levels. Market growth is further supported by laboratory infrastructure expansion, replacement of aging equipment, stricter biosafety practices, and increasing adoption of certified containment systems.
Class II segment captured the largest share of the biological safety cabinet market in 2025.
Based on type, the biological safety cabinet market is segmented into Class I, Class II, and Class III. Among these, the Class II segment accounted for the largest market share in 2025, primarily due to its widespread adoption across pharmaceutical, biopharmaceutical, clinical, academic, and microbiology laboratories. Class II cabinets provide personnel, product, and environmental protection, making them suitable for handling a broad range of biological materials and infectious agents.
The dominance of Class II cabinets is further supported by their broad range of configurations, including Type A1, A2, B1, B2, and C1, allowing laboratories to select systems based on airflow, exhaust, and containment requirements. Type A2 cabinets are widely used for routine microbiological and cell culture applications. Increasing investments in pharmaceutical and biopharmaceutical research, clinical diagnostics, infectious disease studies, and laboratory infrastructure, along with replacement of aging equipment and growing emphasis on certified containment systems, are expected to sustain demand for Class II biological safety cabinets during the forecast period.
Pharma & biopharma organizations to register the highest CAGR in the biological safety cabinet market from 2026 to 2031.
Based on end user, the biological safety cabinet market is segmented into pharma & biopharma organizations, clinical laboratories, academic & biomedical research institutes, and other end users. Among these, the pharma & biopharma organizations segment is projected to register the highest CAGR during the forecast period, driven by increasing investments in drug discovery, biologics, vaccines, cell and gene therapies, and biopharmaceutical manufacturing. These organizations extensively use biological safety cabinets for handling biological materials, infectious agents, cell cultures, and other potentially hazardous substances while maintaining personnel, product, and environmental protection. The growing emphasis on laboratory biosafety, contamination control, and compliance with applicable cabinet performance and certification requirements is expected to drive replacement and new-installation demand across pharmaceutical and biopharmaceutical facilities during the forecast period.
North America to account for the largest share of the biological safety cabinet market in 2025.
The biological safety cabinet market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to account for the largest market share in 2025, supported by its well-established pharmaceutical and biopharmaceutical industries, extensive laboratory infrastructure, and high investments in life sciences research. The US represents the major contributor to regional demand, supported by strong biotechnology and pharmaceutical activity, established clinical and academic research facilities, and the presence of leading biological safety cabinet manufacturers. Regional demand is further supported by expanding biopharmaceutical research, infectious disease studies, clinical diagnostics, and laboratory modernization. Increasing emphasis on laboratory biosafety, containment, and certification is encouraging the adoption and replacement of biological safety cabinets across pharmaceutical, biopharmaceutical, clinical, and research facilities. Class II cabinets account for a substantial portion of regional demand because of their broad application and ability to provide personnel, product, and environmental protection.
Major players operating in the biological safety cabinet market are Thermo Fisher Scientific Inc. (US), Kewaunee Scientific Corporation (US), Labconco Corporation (US), The Baker Company, Inc. (US), Esco Lifesciences (Singapore), Air Science (USA), Cruma, S.A. (Spain), Berner International GmbH (USA), LaboGene ApS (Denmark), Biolab Scientific Ltd. (Canada), LAMSYSTEMS GmbH (Germany), and FASTER S.r.l. (Italy) among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Biological Safety Cabinet Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
